J Drugs Dermatol. 2022 May 1;21(5):545-547. doi: 10.36849/JDD.6189.
At the onset of the COVID-19 pandemic, many Mohs micrographic surgeries (MMS) were delayed over concerns for propagating further infectious spread and scarcity of medical resources.
To assess the impact of the pandemic on MMS and the treatment of skin cancer Methods and Materials: An electronic survey was sent to fellowship trained Mohs surgeons to assess patient outcomes, practice viability, and physician sentiment related to performing MMS during the COVID-19 pandemic.
Of the 303 respondents, 82% reported declines in case volume for at least 3 months, and average case difficulty increased for 69% of surgeons following these delays. Instances of local tumor spread following delays were seen by 69% of respondents, and 20% noted cases of regional or systemic metastasis. Only 8 cases of staff testing positive (and 7 cases of patients) were reported, and 97% of respondents felt comfortable performing MMS during the pandemic. Private practice surgeons more often viewed practice restriction recommendations negatively initially (42% vs 26% in academics, P=0.03) and in hindsight (63% vs 36% in academics, P<0.001).
Mohs surgeon’s ability to minimize spread of COVID-19 during routine patient care, alongside potential risks of delaying treatment of skin cancers, should be considered in future recommendations for patient care. J Drugs Dermatol. 2022;21(5):545-547. doi:10.36849/JDD.6189.
在 COVID-19 大流行期间，由于担心进一步传播感染和医疗资源短缺，许多 Mohs 显微手术（MMS）被推迟。
评估大流行对 MMS 和皮肤癌治疗的影响。
向 fellowship 培训的 Mohs 外科医生发送电子调查，以评估与 COVID-19 大流行期间进行 MMS 相关的患者结局、实践可行性和医生意见。
在 303 名受访者中，82%的人报告说至少有 3 个月的病例量下降，69%的外科医生在这些延迟后，平均病例难度增加。69%的受访者观察到局部肿瘤扩散的情况，20%的人注意到局部或全身转移的情况。仅报告了 8 例工作人员检测呈阳性（7 例患者），97%的受访者在大流行期间感到舒适地进行 MMS。私人执业外科医生最初更倾向于对实践限制建议持负面看法（42%对学术界的 26%，P=0.03），事后看来也是如此（63%对学术界的 36%，P<0.001）。
在常规患者护理期间，Mohs 外科医生应尽量减少 COVID-19 的传播，同时考虑延迟皮肤癌治疗的潜在风险，这应在未来的患者护理建议中加以考虑。J 皮肤病药物杂志。2022；21（5）：545-547.doi：10.36849/JDD.6189.
